Structural studies on α-GAL and α-NAGAL: The atomic basis of Fabry and Schindler diseases

References

• Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L. Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency. N Engl J Med 1967; 276: 1163–1167
   PubMed Web of Science ®Google Scholar
• Davies G, Henrissat B. Structures and mechanisms of glycosyl hydrolases. Structure 1995; 3: 853–859
   PubMed Web of Science ®Google Scholar
• Desnick, RJ, Ioannou, YA, Eng, CM. 2001. α-Galactosidase A Deficiency: Fabry Disease. In: CR Scriver, Beaudet, AL, Sly, WS, Valle, D, editors. New York: McGraw-Hill. p 3733–3774.
   Google Scholar
• Desnick RJ, Schindler D. α-N-Acetylgalactosaminidase Deficiency: Schindler Disease. The Metabolic and Molecular Bases of Inherited Disease, C R Scriver, AL Beaudet, WS Sly, D Valle. McGraw-Hill, New York 2001; 3483–3505
   Google Scholar
• Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, Caplan L, Linthorst GE, Desnick RJ. Safety and efficacy of recombinant human α-galactosidase A—replacement therapy in Fabry's disease. N Engl J Med 2001; 345: 9–16
   PubMed Web of Science ®Google Scholar
• Fabry J. Ein Beitrag Zur Kenntnis der Purpura haemorrhagica nodularis (Purpura papulosa hemorrhagica Habrae). Arch Dermatol Syph 1898; 43: 187
   Google Scholar
• Fan JQ, Ishii S, Asano N, Suzuki Y. Accelerated transport and maturation of lysosomal α-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor. Nat Med 1999; 5: 112–115
   PubMed Web of Science ®Google Scholar
• Frustaci A, Chimenti C, Ricci R, Natale L, Russo MA, Pieroni M, Eng CM, Desnick RJ. Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy. N Engl J Med 2001; 345: 25–32
   PubMed Web of Science ®Google Scholar
• Fujimoto Z, Kaneko S, Momma M, Kobayashi H, Mizuno H. Crystal structure of rice α-galactosidase complexed with d-galactose. J Biol Chem 2003; 278: 20313–20318
   PubMed Web of Science ®Google Scholar
• Garman SC, Garboczi DN. Structural basis of Fabry disease. Mol Genet Metab 2002; 77: 3–11
   PubMedGoogle Scholar
• Garman SC, Garboczi DN. The molecular defect leading to Fabry disease: structure of human α-galactosidase. J Mol Biol 2004; 337: 319–335
   PubMed Web of Science ®Google Scholar
• Garman SC, Hannick L, Zhu A, Garboczi DN. The 1.9 Å structure of α-N-acetylgalactosaminidase: molecular basis of glycosidase deficiency diseases. Structure 2002; 10: 425–434
   PubMed Web of Science ®Google Scholar
• Golubev AM, Nagem RA, Brandao Neto JR, Neustroev KN, Eneyskaya EV, Kulminskaya AA, Shabalin KA, Savel'ev AN, Polikarpov I. Crystal structure of alpha-galactosidase from Trichoderma reesei and its complex with galactose: implications for catalytic mechanism. J Mol Biol 2004; 339: 413–422
   PubMed Web of Science ®Google Scholar
• Kampmann C, Baehner F, Whybra C, Martin C, Wiethoff CM, Ries M, Gal A, Beck M. Cardiac manifestations of Anderson-Fabry disease in heterozygous females. J Am Coll Cardiol 2002; 40: 1668–1674
   PubMedGoogle Scholar
• Kanzaki T, Yokota M, Mizuno N, Matsumoto Y, Hirabayashi Y. Novel lysosomal glycoaminoacid storage disease with angiokeratoma corporis diffusum. Lancet 1989; 1: 875–877
   PubMedGoogle Scholar
• Koshland DE. Stereochemistry and the mechanism of enzymatic reactions. Biol Rev Cambridge Philos Soc 1953; 28: 416–436
   Web of Science ®Google Scholar
• Lee K, Jin X, Zhang K, Copertino L, Andrews L, Baker-Malcolm J, Geagan L, Qiu H, Seiger K, Barngrover D, McPherson JM, Edmunds T. A biochemical and pharmacological comparison of enzyme replacement therapies for the glycolipid storage disorder Fabry disease. Glycobiology 2003; 13: 305–313
   PubMed Web of Science ®Google Scholar
• Matsuda J, Suzuki O, Oshima A, Yamamoto Y, Noguchi A, Takimoto K, Itoh M, Matsuzaki Y, Yasuda Y, Ogawa S, Sakata Y, Nanba E, Higaki K, Ogawa Y, Tominaga L, Ohno K, Iwasaki H, Watanabe H, Brady RO, Suzuki Y. Chemical chaperone therapy for brain pathology in GM1-gangliosidosis. Proc Natl Acad Sci USA 2003; 100: 15912–15917
   PubMed Web of Science ®Google Scholar
• Nakao S, Takenaka T, Maeda M, Kodama C, Tanaka A, Tahara M, Yoshida A, Kuriyama M, Hayashibe H, Sakuraba H, et al. An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N Engl J Med 1995; 333: 288–293
   PubMed Web of Science ®Google Scholar
• Park J, Murray GJ, Limaye A, Quirk JM, Gelderman MP, Brady RO, Qasba P. Long-term correction of globotriaosylceramide storage in Fabry mice by recombinant adeno-associated virus-mediated gene transfer. Proc Natl Acad Sci USA 2003; 100: 3450–3454
   PubMed Web of Science ®Google Scholar
• Ries M, Gupta S, Moore DF, Sachdev V, Quirk JM, Murray GJ, Rosing DR, Robinson C, Schaefer E, Gal A, Dambrosia JM, Garman SC, Brady RO, Schiffmann R. Pediatric Fabry disease. Pediatrics 2005; 115: 344–355
   PubMed Web of Science ®Google Scholar
• Rye CS, Withers SG. Glycosidase mechanisms. Curr Opin Chem Biol 2000; 4: 573–580
   PubMed Web of Science ®Google Scholar
• Schiffmann, R, Kopp, JB, Austin, HA, 3rd, Sabnis, S, Moore, DF, Weibel, T, Balow, JE, Brady, RO. 2001. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA, 285:2743–2749.
   PubMed Web of Science ®Google Scholar
• Schindler D, Bishop DF, Wolfe DE, Wang AM, Egge H, Lemieux RU, Desnick RJ. Neuroaxonal dystrophy due to lysosomal α-N-acetylgalactosaminidase deficiency. N Engl J Med 1989; 320: 1735–1740
   PubMed Web of Science ®Google Scholar
• van Diggelen OP, Schindler D, Kleijer WJ, Huijmans JM, Galjaard H, Linden HU, Peter-Katalinic J, Egge H, Dabrowski U, Cantz M. Lysosomal α-N-acetylgalactosaminidase deficiency: a new inherited metabolic disease. Lancet 1987; 2: 804
   PubMedGoogle Scholar
• van Diggelen OP, Schindler D, Willemsen R, Boer M, Kleijer WJ, Huijmans JG, Blom W, Galjaard H. α-N-acetylgalactosaminidase deficiency, a new lysosomal storage disorder. J Inherit Metab Dis 1988; 11: 349–357
   PubMedGoogle Scholar
• Vasella A, Davies GJ, Bohm M. Glycosidase mechanisms. Curr Opin Chem Biol 2002; 6: 619–629
   PubMed Web of Science ®Google Scholar